Erythropoietin, aluminium, and anaemia in patients on haemodialysis
- PMID: 1967718
- DOI: 10.1016/0140-6736(90)90067-f
Erythropoietin, aluminium, and anaemia in patients on haemodialysis
Abstract
Effects of erythropoietin treatment on haem synthesis in peripheral blood were evaluated in 11 patients on haemodialysis. After 2 weeks of erythropoietin, mean (SEM) uroporphyrinogen-l synthase activity increased significantly from 88 (10) to 116 (9) pmol/h per mg protein. Haem synthase activity, thought to be the rate-limiting step in erythroid haem synthesis, also showed a significant increase from 4.5 (0.8) to 8.4 (1.8) pmol/h per 10(6) reticulocytes. 4 patients, who showed only a partial response to erythropoietin, had significantly higher serum aluminium concentrations than the 7 who responded fully (225 [44] vs 55 [23] micrograms/l); erythrocyte protoporphyrin concentrations in partial responders were also much higher than in responders (973 [120] vs 388 [29] nmol/l). Aluminium intoxication may cause resistance to erythropoietin by interference with haem synthesis, with accumulation of protoporphyrin.
Comment in
-
Erythropoietin, aluminium, and anaemia in patients on haemodialysis.Lancet. 1990 Apr 28;335(8696):1038-9. doi: 10.1016/0140-6736(90)91104-i. Lancet. 1990. PMID: 1970090 No abstract available.
-
Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.Lancet. 1990 Jun 16;335(8703):1465. doi: 10.1016/0140-6736(90)91493-t. Lancet. 1990. PMID: 1972238 No abstract available.
-
Erythropoietin, aluminium, and anaemia in patients on haemodialysis.Lancet. 1990 Jul 28;336(8709):255-6. doi: 10.1016/0140-6736(90)91788-c. Lancet. 1990. PMID: 1973809 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
